BAUSCH HEALTH COS INC (BHC) Stock News
NYSE:BHC - New York Stock Exchange, Inc. - CA0717341071 - Common Stock - Currency: USD
BHC Latest News, Press Relases and Analysis
Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90%
Carl Icahn boosts holdings in Illumina and JetBlue, showing confidence in biotech and airlines. He also trims exposure to Southwest Gas Holdings.
Bausch Health Announces 2025 Annual Meeting of Shareholder Results
Mentions: BHC.CA
New Strong Sell Stocks for May 13th
ALTI, AMRK and BHC have been added to the Zacks Rank #5 (Strong Sell) List on May 13, 2025.
Thryv Holdings, Inc. (THRY): A Bull Case Theory
We came across a bullish thesis on Thryv Holdings, Inc. (THRY) on Substack by Inflexio Research. In this article, we will summarize the bulls’ thesis on THRY. Thryv Holdings, Inc. (THRY)’s share was trading at $13.83 as of May 5th. THRY’s trailing and forward P/E were 15.31 and 19.76 respectively according to Yahoo Finance. Thryv (THRY) reported […]
Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System
Mentions: BHC.CA
Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM)
Mentions: BHC.CA
Alphabet Inc. (GOOGL): Among Billionaire John Paulson’s Stocks with Huge Upside Potential
We recently published a list of Billionaire John Paulson’s 10 Stocks with Huge Upside Potential. In this article, we are going to take a look at where Alphabet Inc. (NASDAQ:GOOGL) stands against other stocks with huge upside potential. John Alfred Paulson is an American billionaire hedge fund manager who founded Paulson & Co. in 1994. It is […]
Bausch Health Companies Inc. (BHC): Among Billionaire John Paulson’s Stocks with Huge Upside Potential
We recently published a list of Billionaire John Paulson’s 10 Stocks with Huge Upside Potential. In this article, we are going to take a look at where Bausch Health Companies Inc. (NYSE:BHC) stands against other stocks with huge upside potential. John Alfred Paulson is an American billionaire hedge fund manager who founded Paulson & Co. in 1994. […]
Alibaba Group Holding Limited (BABA): Among David Tepper’s Stock Picks with Huge Upside Potential
We have published an article titled Billionaire David Tepper’s 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Alibaba Group Holding Limited (NYSE:BABA) stands against David Tepper’s other stock picks. The S&P 500 has returned 12.29% over the past 12 months as of May 2, 2025. […]
Bausch Health Announces Filing of Supplement to Proxy Statement
Mentions: BHC.CA
Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program
Mentions: BHC.CA
QUALCOMM Incorporated (QCOM): Among David Tepper’s Stock Picks with Huge Upside Potential
We have published an article titled Billionaire David Tepper’s 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where QUALCOMM Incorporated (NASDAQ:QCOM) stands against David Tepper’s other stock picks. The S&P 500 has returned 12.29% over the past 12 months as of May 2, 2025. In the […]
Bausch Health Q1 Earnings and Revenues Miss Estimates, Stock Down
BHCs first-quarter 2025 adjusted earnings and revenues miss estimates. Salix performs lower than expected. Stock declines.
Bausch (BHC) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Bausch (BHC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Bausch Health (BHC) Q1 Earnings and Revenues Lag Estimates
Bausch (BHC) delivered earnings and revenue surprises of -28.92% and 0.54%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: PSNL
Ashley McEvoy named Insulet CEO
McEvoy, the former leader of Johnson & Johnson’s medtech business, started immediately. Jim Hollingshead, who was CEO of Insulet for three years, resigned on Monday but will work as a consultant.
4 Ways To Plan for Healthcare Costs in an Inflationary Economy
By now we all know that inflation has pretty much affected the cost of everything in recent years -- from gas and groceries to housing and healthcare. However, according to Wayne Winegarden, an...
Will Bausch (BHC) Beat Estimates Again in Its Next Earnings Report?
Bausch (BHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Danaher price target lowered to $240 from $260 at Goldman Sachs
Goldman Sachs analyst Matthew Sykes lowered the firm’s price target on Danaher (DHR) to $240 from $260 but keeps a Buy rating on the shares after its Q1 results. The company’s Bioprocessing business continues to improve, and the current tariff headwind appears manageable, the analyst tells investors in a research note. Despite the top and bottom line beat in the quarter however, there is still merit in the prudent approach with Danaher maintaining prior FY25 guidance given all the moving parts a
Why Pony AI Stock Skyrocketed on Wednesday
The robotaxi provider announced ambitious plans for a product rollout.
Is Bausch Health Companies Inc. (BHC) the Best Canadian Penny Stock to Invest in Now?
We recently published a list of 13 Best Canadian Penny Stocks to Invest in Now In this article, we are going to take a look at where Bausch Health Companies Inc. (NYSE:BHC) stands against other best Canadian penny stocks to invest in now. We define penny stocks as shares trading under $5.00, which usually fall […]
Bausch Health (BHC) Reports Next Week: Wall Street Expects Earnings Growth
Bausch (BHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: BBIO
Bausch Health Says Carl Icahn Has 34% Economic Interest In Its Outstanding Shares
This disclosure comes days after the company announced a new “poison pill” plan to safeguard shareholders’ rights and prevent hostile takeovers.
Mentions: BA
Is Bausch + Lomb (BLCO) the Most Undervalued Canadian Stock to Buy According to Wall Street Analysts?
We recently published a list of the 10 Most Undervalued Canadian Stocks to Buy According to Wall Street Analysts. In this article, we are going to take a look at where Bausch + Lomb Corporation (NYSE:BLCO) stands against other undervalued Canadian stocks according to Wall Street analysts. As February was concluding, Reuters reported that Canada’s […]
Bausch Health says Carl Icahn has exposure to about 34% of company's shares
Earlier this month, Bausch Health said it had adopted a shareholders' rights plan, also known as a "poison pill", to fend off any potential hostile takeovers and prevent investors from acquiring a more than 20% stake in the company. In a supplement to its proxy filing, the company said Icahn refused to provide copies of the swap agreements to Bausch's lawyers, but has said they were accumulated between May 2021 and September 2023.
Mentions: TSLA
Is Bausch Health Companies (BHC) the Ridiculously Cheap Stock to Invest in?
We recently published a list of 11 Ridiculously Cheap Stocks to Invest in. In this article, we are going to take a look at where Bausch Health Companies Inc. (NYSE:BHC) stands against other ridiculously cheap stocks to invest in. Just as we hunt for bargains in the commodity market—comparing relative prices, identifying discounted products, and […]
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
Mentions: BHC.CA
Fitch Upgrades Bausch + Lomb, Bausch Health But Keeps Both Junk
Fitch Ratings upgraded its credit grade on both Bausch + Lomb Corp. and its parent company Bausch Health Cos., but said the eye care unit’s ratings will continue to be under pressure unless the two separate.
Bausch Health Announces Adoption of Shareholder Rights Plan
Mentions: BHC.CA
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
Mentions: BHC.CA
S&P 500 Sinks 2% as Economic Fears Spur Bond Rally: Markets Wrap
(Bloomberg) -- Stocks got hammered, bonds climbed and gold hit a record high, following signs of weakness in the main engine of the US economy and worries that inflation could gain further traction amid a trade war.Most Read from BloombergGold-Rush Fever Returns to Historic New Zealand Mining TownWhat Frank Lloyd Wright Learned From the DesertHow SUVs Are Making Traffic WorseTrump Slashed International Aid. Geneva Is Feeling the Impact.Bank Regulators Fight for Desks as OCC Returns to New York T
Bausch Health to Announce First Quarter Results on April 30
Mentions: BHC.CA
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes
Mentions: BHC.CA
Bausch Health Announces Conditional Redemption of Senior Notes
Mentions: BHC.CA